Darren Cross
4PUBLICATIONS
55CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Dec 12, 2022
Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancer.Sally J Adua, Anna Arnal-Estapé, Minghui Zhao
|Oct 20, 2022
Osimertinib + Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor-Mutated, MET-Amplified Non-Small Cell Lung Cancer: TATTON.Ryan J Hartmaier, Aleksandra A Markovets, Myung Ju Ahn
|Sep 13, 2021
Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR-mutant lung cancer.Pınar Özden Eser, Raymond M Paranal, Jieun Son
|May 18, 2021
Kinase drug discovery 20 years after imatinib: progress and future directions.Philip Cohen, Darren Cross, Pasi A Jänne
Pageof 1
Frequent Collaborators
3 joint publications
Pasi A Jänne
2 joint publications
Paul Smith
1 joint publications
Ryan J Hartmaier
1 joint publications
Aleksandra A Markovets
1 joint publications
Myung Ju Ahn
1 joint publications
Lecia V Sequist
1 joint publications
Ji-Youn Han
1 joint publications
Byoung Chul Cho
1 joint publications
Don X Nguyen
1 joint publications
Sang-We Kim
